Ferrous gluconate

Generic Medicine Info
Should be taken on an empty stomach. Best taken on an empty stomach. May be taken w/ meals to reduce GI discomfort.
Haemochromatosis, haemosiderosis, haemoglobinuria, anaemias not caused by Fe deficiency (e.g. thalassaemia), active peptic ulcer, regional enteritis, ulcerative colitis, alcoholism, hepatitis. Patients receiving repeated blood transfusions or parenteral Fe therapy.
Special Precautions
Patient w/ intestinal strictures and diverticular disease, haemolytic anaemia, Fe absorption disorders. Childn. Pregnancy and lactation. Patient Counselling This drug may cause black discolouration of the stool. Monitoring Parameters Monitor serum Fe, total Fe binding capacity, Hb, and reticulocyte count.
Adverse Reactions
GI: GI discomfort, anorexia, nausea, vomiting, heartburn, constipation or diarrhroea, faecal impaction, dark stools, dental discolouration. Genitourinary: Urine discolouration. Dermatologic: Allergic reactions, contact dermatitis.
Drug Interactions
May form a chelate w/ acetohydroxamic acid, resulting in reduced absorption of both drugs. Toxic compounds may be formed w/ concomitant use of dimercaprol. Decreased absorption w/ antacids containing Ca salts, carbonates or Mg trisilicate, and other drugs containing bicarbonates, carbonates, oxalates or phosphates due to formation of less soluble or insoluble complexes. Reduced absorption w/ trientine, cholestyramine, tetracyclines, Zn, PPIs. Increased absorption w/ ascorbic and succinic acid. Haematologic response may be impaired when used w/ vit E. Antagonises the hypotensive effect of methyldopa. May reduce the absorption of penicillamine, bisphosphonates, fluoroquinolones, entacapone, mycophenolate, tetracyclines, Zn, levothyroxine, levodopa, carbidopa, nalidixic acid, eltrombopag. Neomycin may alter the absorption of Fe. Oral chloramphenicol delays plasma Fe clearance, incorporation into RBC and interferes w/ erythropoiesis.
ATC Classification
B03AD05 - ferrous gluconate
B03AA03 - ferrous gluconate ; Belongs to the class of oral iron bivalent preparations. Used in the treatment of anemia.
Disclaimer: This information is independently developed by CIMS based on ferrous gluconate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in